Abstract:Pancreatic ductal adenocarcinoma (PDAC) is distinguished by its aggressive malignancy, limited treatment avenues and a tendency towards chemotherapy resistance, underscoring the critical need for advanced research to uncover new therapeutic approaches. Stress granules (SGs) that is implicated in cellular self-protection mechanism, along with its associated family molecules have shown pro-cancer effects and are closely related to tumor chemotherapy resistance. In this study we investigated the relationship between Ras GTPase-activating protein-binding proteins 2 (G3BP2), a core component of SGs, and the malignancy of PDAC as well as its resistance to the chemotherapy drug gemcitabine. Analyzing TCGA dataset revealed that the expression of G3BP1 and G3BP2 was significantly upregulated in PDAC compared with adjacent normal pancreatic tissues, and the high expression of G3BP2 rather than G3BP1 was significantly associated with poorer overall survival (OS) in PDAC patients. We demonstrated that knockdown of G3BP2 inhibited the proliferation and invasion of PANC-1 and CFPAC-1 cells in vitro and in vivo. By analyzing the differentially expressed genes in G3BP2 knockdown and overexpressed PANC-1 cells, we identified DKC1 that was associated with RNA stability and regulation as the target of G3BP2. We demonstrated that G3BP2 bound to PDIA3 mRNA and recruited them into SGs, increasing the stability of PDIA3 mRNA and attenuating its translation efficiency, thereby promoting DKC1 expression. Furthermore, DKC1 could bind to hENT mRNA and inhibited its expression, which enhanced gemcitabine resistance of PDAC. Therefore, we propose a novel mechanism wherein G3BP2 facilitates PDAC's resistance to chemotherapy by modulating PDIA3-DKC1-hENT in a SGs-dependent way, suggesting G3BP2 SGs a protentional therapeutic target for the treatment in PDAC.

G3BP2: Structure and function

Research Progress on the Structure and Function of G3BP

Identification and Characterization of Mouse GTPBP3 Gene Encoding a Mitochondrial GTP-binding Protein Involved in Trna Modification

G3BP1 promotes human breast cancer cell proliferation through coordinating with GSK-3β and stabilizing β-catenin

G3BP isoforms differentially affect stress granule assembly and gene expression during cellular stress

G3BP1 Regulates Breast Cancer Cell Proliferation and Metastasis by Modulating PKCζ

Targeting IGF2BP3 in Cancer

Regulation of PMP22 mRNA by G3BP1 affects cell proliferation in breast cancer cells

Stress granule-associated protein G3BP2 regulates breast tumor initiation

Expressions of G3BP1 and G3BP2 proteins in colorectal cancer and their clinical significances

G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules

G3BP1 Contributes to Tumor Metastasis Via Upregulation of Slug Expression in Hepatocellular Carcinoma.

BP 1 contributes to tumor metastasis via upregulation of Slug expression in hepatocellular carcinoma

G3BP2 regulates oscillatory shear stress-induced endothelial dysfunction

The structure and function of multifunctional protein ErbB3 binding protein 1 (Ebp1) and its role in diseases

G3BP1 Maintains Vascular Endothelial Barrier Integrity by Negatively Regulating the MYD88-ARNO-ARF6 Signaling Pathway

Overexpression of Ras-GTPase-activating Protein SH3 Domain-Binding Protein 1 Correlates with Poor Prognosis in Gastric Cancer Patients.

GTPBP2 positively regulates the invasion, migration and proliferation of non-small cell lung cancer

G3BP1 May Serve As a Potential Biomarker of Proliferation, Apoptosis, and Prognosis in Oral Squamous Cell Carcinoma.

Expression of G3BP1 in Benign and Malignant Human Prostate Tissues

G3BP2 promotes tumor progression and gemcitabine resistance in PDAC via regulating PDIA3-DKC1-hENT in a stress granules-dependent manner